Gene Synthesis Market Overview:
As per MRFR analysis, the Gene Synthesis Market Size was estimated at 2.28 (USD Billion) in 2023. The Gene Synthesis Market Industry is expected to grow from 2.53(USD Billion) in 2024 to 8 (USD Billion) by 2035. The Gene Synthesis Market CAGR (growth rate) is expected to be around 11.03% during the forecast period (2025 - 2035).
Key Gene Synthesis Market Trends Highlighted
The Global Gene Synthesis Market is experiencing significant trends driven by advances in biotechnology and increasing research and development activities across regions. Key market drivers include the growing demand for synthetic genes in pharmaceuticals and agriculture aimed at developing new treatments and improving crop yields.
The rising application of synthetic biology in diverse fields such as diagnostics, therapeutics, and environmental sustainability is propelling the market forward. Additionally, the increasing number of research institutions and collaborations globally underscores the importance of gene synthesis in various scientific pursuits.
Opportunities to be explored encompass the potential for personalized medicine and gene therapies as the healthcare sector increasingly seeks tailored solutions. The collaboration between academic institutions and businesses is fostering innovation and creativity in gene synthesis technologies, enabling faster and more efficient production processes.
As the market evolves, there is an increasing emphasis on automation and artificial intelligence, which could enhance accuracy and reduce turnaround times in gene synthesis. Trends in recent times indicate a notable shift towards the adoption of CRISPR technology and genome editing techniques within synthetic biology.
This requires a steady supply of synthesized genes, thus driving market growth. Furthermore, the regulatory environments across different countries are becoming more conducive to gene synthesis research, promoting international collaboration and data sharing among scientists. Overall, the Global Gene Synthesis Market is poised for growth, with expanding applications and technological advancements creating a dynamic environment for industry stakeholders.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Gene Synthesis Market Drivers
Increasing Demand for Synthetic Biology
The increasing demand for synthetic biology applications is driving a significant acceleration in the global gene synthesis market. Designing and building new biological components and systems is made easier by synthetic biology, which has important ramifications for biomanufacturing, agriculture, and medicines. The synthetic biology industry is expected to expand at a compound annual growth rate of around 25.69%, from USD 7.1 billion in 2017 to USD 40.8 billion by 2025, according to research released by the European Association for Bioindustries.
Large institutions like Harvard University and the National Aeronautics and Space Administration (NASA) are making significant investments in synthetic biology projects, which are boosting international research efforts and spurring advancements in gene synthesis technology. This increased interest is crucial since it advances genetic engineering and editing, which helps the global gene synthesis market industry expand overall.
Technological Advancements in Gene Synthesis
Rapid technological advancements in gene synthesis methodologies are significantly fueling growth within the Global Gene Synthesis Market Industry. Next-generation sequencing and advanced polymerase chain reaction technologies allow for the fast and accurate synthesis of DNA sequences. The National Institutes of Health reported that the costs of sequencing a human genome declined from nearly USD 100 million in 2001 to less than USD 1,000 in 2021, thereby making genetic research more accessible.
Companies like Illumina Inc. and Thermo Fisher Scientific are continuously developing and refining their technologies, ensuring that researchers have access to robust and efficient tools for gene synthesis, thereby catalyzing further innovation in biotechnology sectors.
Rising Applications in Personalized Medicine
Personalized medicine is becoming a major driver of the Global Gene Synthesis Market Industry. With advancements in genomic medicine and biological research, the applications of gene synthesis are becoming increasingly sophisticated. The World Health Organization has highlighted the importance of personalizing treatment based on genetic information, forecasting that by 2025, personalized medicine could create a market value of around USD 2.5 trillion globally.
Companies such as BGI Genomics and GeneDx are committed to promoting genetic testing services that enable tailored treatments to improve patient outcomes. This endeavor not only reflects the market's growth potential but also highlights the relevance of gene synthesis in redefining treatment paradigms globally.
Gene Synthesis Market Segment Insights:
Gene Synthesis Market Application Insights
The Global Gene Synthesis Market is witnessing significant growth across various applications, which play vital roles in advancing fields such as healthcare, agriculture, and synthetic biology. In 2024, the market is generated a revenue of 2.53 USD Billion and is projected to reach 8.0 USD Billion by 2035, reflecting the increasing demand for precision in genetic modification and design. Within this expansive market, key applications like Synthetic Biology, Therapeutics, Vaccines, Genetic Engineering, and Agricultural Biotechnology are driving substantial contributions. Synthetic Biology is anticipated to hold a major share of the market with a valuation of 0.76 USD Billion in 2024, expanding to 2.4 USD Billion by 2035, as it not only focuses on designing new biological parts but also enhances existing systems for practical use.
The Therapeutics application is valued at 0.63 USD Billion in 2024 and is set to grow to 1.85 USD Billion by 2035, indicating a strong emphasis on personalized medicine and targeted treatments, which reflect the need for advanced solutions in healthcare. Vaccines, critical during health crises, are projected to generate 0.48 USD Billion in 2024 and reach 1.44 USD Billion by 2035, underscoring the essentiality of rapid vaccine development and production in combating infectious diseases.
Genetic Engineering, pivotal in modifying organisms for various purposes, is set to be valued at 0.42 USD Billion in 2024, growing to 1.26 USD Billion by 2035, which emphasizes its key role in creating genetically modified organisms (GMOs) and improving livestock and crops for higher yield.
Furthermore, Agricultural Biotechnology, while currently the smallest segment at 0.24 USD Billion in 2024, is expected to grow to 0.75 USD Billion by 2035, highlighting the increasing focus on improving food security through genetically enhanced crops. This collective growth across application sectors reflects the broad and transformative potential of gene synthesis technologies in addressing global challenges.
As the need for sustainable agricultural practices and efficient healthcare solutions intensifies, investments in these applications are likely to rise, contributing to the ongoing evolution of the Global Gene Synthesis Market industry. The prevailing trends, growth drivers, and challenges are closely linked to the advancement of scientific research, regulatory frameworks, and the continuous demand for innovative solutions in diverse sectors.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Gene Synthesis Market Product Type Insights
The Global Gene Synthesis Market is poised for significant growth, with a valuation of 2.53 USD Billion in 2024, expanding to 8.0 USD Billion by 2035, reflecting the increasing demand for advanced genetic engineering technologies. Within this market, various product types play crucial roles, particularly Gene Libraries, Oligonucleotides, Plasmids, and Gene Fragments. Gene Libraries enable researchers to access a wide array of genetic sequences, fostering innovation and applications in synthetic biology and biotechnology.
Oligonucleotides, essential components in gene synthesis, are widely utilized in research and clinical applications, driving substantial interest in the market.Plasmids serve as vital tools in gene cloning and genetic manipulation, highlighting their dominance and importance in the biotechnology landscape.
Gene Fragments are integral for various synthetic applications, enabling precise control over genetic engineering processes. The market trends indicate growing investments in Research and Development and breakthroughs in genetic engineering are anticipated to propel the Global Gene Synthesis Market revenue further. Challenges in regulation and quality control remain, yet the market continues to thrive, presenting opportunities for innovations and strategic partnerships.The Global Gene Synthesis Market statistics underscore a dynamic industry landscape characterized by rapid advancements and evolving consumer needs.
Gene Synthesis Market Technology Insights
The Global Gene Synthesis Market shows significant promise within the Technology segment, valued at 2.53 USD Billion in 2024 and grow to 8.0 USD Billion by 2035. This growth trajectory highlights the increasing demand for advanced genetic engineering solutions. Within this segment, various technologies play crucial roles, with Polymerase Chain Reaction being essential for amplifying DNA samples, thus enabling precise analysis. Microarray Technology facilitates the simultaneous analysis of thousands of genes, revolutionizing research applications.
DNA Sequencing is a fundamental tool for understanding genetic information, driving advances in personalized medicine and biotechnology. Automated Synthesis is gaining traction for its efficiency, significantly reducing time in genetic research and application. The intersection of these technologies fosters innovation in the Global Gene Synthesis Market, with continual advancements driving market growth and capturing the interest of researchers and institutions globally.
Factors such as increased funding for Research and Development, along with the rising prevalence of genetic disorders, underscore the growing importance of these technologies in addressing global health challenges.As the market evolves, it presents numerous opportunities for stakeholders seeking to contribute to biotechnological advancements.
Gene Synthesis Market End Use Insights
The Global Gene Synthesis Market revenue is gaining momentum as it captures the interests of various End Use sectors. In 2024, the market is valued at 2.53 USD Billion, with significant contributions from Academic Research, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations. Academic Research plays a crucial role in driving innovation in gene manipulation, while Pharmaceutical Companies leverage gene synthesis to expedite drug discovery and development. Biotechnology Companies focusing on synthetic biology are transforming the production of biologics and therapeutics, and Contract Research Organizations enhance efficiencies through outsourcing services.
The market growth in these sectors is fueled by increasing investments in Research and Development, technological advancements, and the rise of personalized medicine. However, challenges such as regulatory hurdles and high costs remain. Opportunities abound in emerging markets and the continued evolution of gene synthesis technologies as organizations seek to capitalize on the expanding applications of engineered genes in diagnostics, agriculture, and environmental management. The Global Gene Synthesis Market statistics indicate a robust evolution, well-aligned with the dynamic landscape of genetic engineering.
Gene Synthesis Market Regional Insights
The Global Gene Synthesis Market is showing significant revenue potential across various regions, with North America leading the way. In 2024, North America is valued at 1.2 USD Billion and is projected to reach 4.0 USD Billion by 2035, showcasing its dominant position in advancements in biomedical research and biotechnology. Europe follows with a valuation of 0.8 USD Billion in 2024 and a forecast of 2.5 USD Billion by 2035, bolstered by strong Research and Development initiatives and academic collaborations. The APAC region, valued at 0.4 USD Billion in 2024, is expected to grow to 1.4 USD Billion by 2035, driven by increasing investments in healthcare infrastructure and genetic research innovations.
South America and the MEA regions, while smaller, with valuations of 0.06 USD Billion and 0.07 USD Billion in 2024, respectively, are anticipated to expand their influence in the market by nurturing local biotechnology firms and fostering a supportive regulatory environment. Overall, the Global Gene Synthesis Market segmentation illustrates a diverse landscape, with North America and Europe exhibiting majority holdings, while the emerging markets in APAC, South America, and MEA provide significant growth opportunities driven by regional initiatives and healthcare demands.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Gene Synthesis Market Key Players and Competitive Insights:
The Global Gene Synthesis Market has seen tremendous growth and innovation due to advancements in biotechnology and personalized medicine. As the demand for synthetic genes continues to escalate across various sectors, including pharmaceuticals, agriculture, and synthetic biology, numerous players are emerging in the market, each vying for a competitive edge. Companies are increasingly investing in research and development to harness advanced technologies such as next-generation sequencing and CRISPR to enhance accuracy, speed, and scalability in gene synthesis.
The competitive landscape is defined by firms engaging in strategic collaborations, mergers, acquisitions, and partnerships aimed at strengthening their market presence and expanding their product offerings. This dynamic market environment fosters innovation and elevates the quality of services available, ultimately driving growth and competition among key stakeholders.
Molecular Assemblies has carved out a niche within the Global Gene Synthesis Market, leveraging its proprietary technology that enables high-fidelity synthesis of longer DNA strands. The company's strength lies in its efficient and reliable workflows that markedly reduce the time and errors associated with traditional methods. By offering superior-quality synthetic DNA at scalable levels, Molecular Assemblies positions itself as a favored partner for biotech firms and academic institutions.
Additionally, the company has focused on developing relationships within specific sectors that benefit from high-quality gene synthesis, such as therapeutics and synthetic biology, further amplifying its influence in the global market. With a commitment to sustainability and efficiency, Molecular Assemblies has set a benchmark in the market, making significant strides that enhance its competitiveness.
Genscript is a formidable player in the Global Gene Synthesis Market, known for its comprehensive portfolio of services that cater to the needs of researchers and developers across various industries. The company excels in providing high-quality gene synthesis, custom DNA products, and cloning services, which are complemented by its advanced technology platforms. Genscript’s key strengths include its extensive experience in molecular biology, large-scale production capabilities, and robust customer support. The company maintains a strong global presence, bolstered by a series of strategic mergers and acquisitions that have expanded its technological capabilities and market reach.
Recently, Genscript has focused on enhancing its service offerings through innovations in automation and workflow solutions, ensuring that it remains at the forefront of customer satisfaction in the gene synthesis arena. Its commitment to quality and operational excellence makes Genscript a critical competitor in the continually evolving landscape of gene synthesis globally.
Key Companies in the Gene Synthesis Market Include:
- Molecular Assemblies
- Genscript
- SRI BiosciencesThermo Fisher Scientific
- Codex Biotechnology
- Integrated DNA Technologies
- Synlogic
- Twist Bioscience
- Illumina
- DNA2.0
- Aldevron
- Assembly Biosciences
- Eurofins Genomics
- Biosynthesis
- Genewiz
Gene Synthesis Market Industry Developments
Recent developments in the Global Gene Synthesis Market highlight a notable surge in investments and technological advancements. Companies such as Molecular Assemblies and Genscript continue to innovate, with a focus on improving the efficiency and accuracy of gene synthesis. In September 2023, Thermo Fisher Scientific announced a strategic collaboration with Illumina to enhance genomic solutions, demonstrating a push towards integrated service offerings. Additionally, Codex Biotechnology reported growth in demand for its custom DNA synthesis, pointing to a broader trend in personalized medicine.
Recent mergers and acquisitions include the acquisition of DNA2.0 by Twist Bioscience in July 2022, which enhanced Twist’s capabilities in gene synthesis and market reach. Eurofins Genomics has also gained significant traction, marking its footprint in the synthetic biology landscape with recent investments. The market saw a valuation increase driven by the rising demand in the biotechnology and pharmaceutical sectors, reflected by increased production capacities by companies like Integrated DNA Technologies and Synlogic. Over the past few years, the overall market has benefited from heightened interest in genetic engineering, particularly in 2021 and 2022, with increasing funding directed towards Research and Development initiatives across the globe.
Gene Synthesis Market Segmentation Insights
Gene Synthesis Market Application Outlook
- Synthetic Biology
- Therapeutics
- Vaccines
- Genetic Engineering
- Agricultural Biotechnology
Gene Synthesis Market Product Type Outlook
- Gene Libraries
- Oligonucleotides
- Plasmids
- Gene Fragments
Gene Synthesis Market Technology Outlook
- Polymerase Chain Reaction
- Microarray Technology
- DNA Sequencing
- Automated Synthesis
Gene Synthesis Market End Use Outlook
- Academic Research
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
Gene Synthesis Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric Source: |
Details |
| MARKET SIZE 2023 |
2.28(USD Billion) |
| MARKET SIZE 2024 |
2.53(USD Billion) |
| MARKET SIZE 2035 |
8.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) |
11.03% (2025 - 2035) |
| REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR |
2024 |
| MARKET FORECAST PERIOD |
2025 - 2035 |
| HISTORICAL DATA |
2019 - 2024 |
| MARKET FORECAST UNITS |
USD Billion |
| KEY COMPANIES PROFILED |
Molecular Assemblies, Genscript, SRI Biosciences, Thermo Fisher Scientific, Codex Biotechnology, Integrated DNA Technologies, Synlogic, Twist Bioscience, Illumina, DNA2.0, Aldevron, Assembly Biosciences, Eurofins Genomics, Biosynthesis, Genewiz |
| SEGMENTS COVERED |
Application, Product Type, Technology, End Use, Regional |
| KEY MARKET OPPORTUNITIES |
Biopharmaceutical development advancements, Synthetic biology innovations, Personalized medicine growth, CRISPR technology integration, Educational research collaborations |
| KEY MARKET DYNAMICS |
Increased demand for personalized medicine, Technological advancements in gene synthesis, Growing biopharmaceutical industry, Rising applications in synthetic biology, Expanding research funding and investments |
| COUNTRIES COVERED |
North America, Europe, APAC, South America, MEA |
Gene Synthesis Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Gene Synthesis Market is expected to reach a valuation of 8.0 USD Billion by 2035.
The market is anticipated to grow at a CAGR of 11.03 percent from 2025 to 2035.
North America is projected to dominate the market, with a value of 4.0 USD Billion by 2035.
By 2035, the European market is expected to be valued at 2.5 USD Billion.
The Synthetic Biology segment is expected to be valued at 2.4 USD Billion by 2035.
The Therapeutics application is forecasted to reach 1.85 USD Billion by 2035.
Major players include Molecular Assemblies, Genscript, SRI Biosciences, and Thermo Fisher Scientific.
The Agricultural Biotechnology segment is projected to reach 0.75 USD Billion by 2035.
The APAC region is expected to grow to 1.4 USD Billion by 2035.
The Vaccines application is expected to be valued at 1.44 USD Billion by 2035.
